KEYTRUDA 100mg (Pembrolizumab) is a prescription drug used to treat a certain type of skin cancer called melanoma and also used to treat a kind of non-small cell lung cancer (NSCLC).
Manufacturer : Merck & Co., Inc.
Strengths available : 100mg
Storage : Store at temperature between 2°C to 8°C
It is US FDA approved
Dosage :
Recommended Dosage for Melanoma
The recommended dose of KEYTRUDA is 200 mg administered as an intravenous infusion over 30 minutes every 3 weeks until disease progression or unacceptable toxicity.
Recommended Dosage for NSCLC
The recommended dose of KEYTRUDA is 200 mg administered as an intravenous infusion over 30 minutes every 3 weeks until disease progression, unacceptable toxicity, or up to 24 months in patients without disease progression.
When administering KEYTRUDA in combination with chemotherapy, KEYTRUDA should be administered prior to chemotherapy when given on the same day [see Clinical Studies (14.2)]. See also the Prescribing Information for pemetrexed and carboplatin.
Most common side effects areShortness of breath, Diarrhea, Nausea or vomiting, Rapid heart beat, Weight loss or weight gain, Increased sweating, Feeling more hungry or thirsty, Urinating more often than usual, Hair loss, Constipation, Dizziness or fainting
Pack of 1 Vial
3S Corporation is a WHO GDSP approved & licensed Pharmaceutical stockist/wholesaler/distributor/exporter/importer of KEYTRUDA Pembrolizumab 100mg Injection based in India - To buy KEYTRUDA Pembrolizumab 100mg Injection or know its cost price contact us here.
We supply & sell KEYTRUDA Pembrolizumab 100mg Injection for Reference Listed Drugs, Government Tenders, Shortage Lists, Emergency Imports, Name Patient Drugs, Comparator Drug Studies, Un-licensed Importation, clinical trial samples & Bio-Similars.
At MBS, we acknowledge the critical role that reliable sourcing and timely delivery play in the healthcare industry. MBS is your trusted partner in pharmaceutical supply chain management.